A Study To Assess the Quality and Strength of Bone in Women Participants With Osteoporosis Taking Oral Ibandronate Versus Placebo

NCT00148915 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoporosis

Interventions

DRUG: ibandronate
DRUG: Placebo

Sponsor

Hoffmann-La Roche